Clinical outcomes associated with elexacaftor/tezacaftor/ivacaftor use in patients with cystic fibrosis following liver transplantation

Category Primary study
JournalJournal of Cystic Fibrosis
Year 2021
This article has no abstract
Epistemonikos ID: 6c4ebbc1b7f815eb13e7a6cff94e1c6a4dabb397
First added on: Feb 13, 2025